Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

General Information

Bioxyne Limited
BXN
http://www.bioxyne.com
Biotechnology
2
200

Current Price Data+

Current Price Open High Low Last Close Volume Price Movement
$0.01 $0.01 $0.01 $0.01 $0.01 1759586 $0.00 ( 8.33% )
  • +Security prices are delayed by least 20 minutes and are indicative only.

Company Overview

Business Description
Bioxyne Limited (BXN) is a biopharmaceutical company focused on manufacture, marketing and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus fermentum. In past years, the principal activities of the Group were the research and development of products for the ongoing treatment of Chronic Obstructive Pulmonary Disease.
Strategy Analysis
--

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2014 A 0.3 0.1 0.0% 7.1 0.0 0.0% 0.0%
2013 A -6.2 -4.0 0.0% 0.0 0.0 0.0% 0.0%
2012 A -0.3 -0.6 0.0% 0.0 0.0 0.0% 0.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2012 A 2013 F 2014 F 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F
Bioxyne (BXN) $3M 0.0000 0.0000 0.0000 9.2857 0.0000 0.0000 0.00% 0.00% 0.00%
CSL (CSL) $44,787M 0.0899 0.3345 0.0817 33.7277 25.2735 23.3644 1.25% 1.65% 1.88%
Mesoblast (MSB) $1,314M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Monash IVF Group (MVF) $324M 0.0000 1.7120 0.3828 37.3641 13.7776 9.9638 0.00% 4.72% 6.52%
Sirtex Medical (SRX) $1,735M 0.2906 0.6077 0.6093 73.5351 45.7380 28.4204 0.46% 0.64% 1.04%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.45 8.57 2.22 0.00
Market 0.97 13.50 1.05 0.47
Sector 0.81 13.20 3.15 1.03

Directors

Name Position Start Date
Mr George Xavier Cameron-Dow Non-Executive Director 21/07/2014
Mr Patrick Douglas Ford Non-Executive Director 20/05/2005
Mr Anthony Peng Ho Non-Executive Director, Non-Executive Chairman 30/10/2012

Management

Name Position
Jarrod Travers White Chief Financial Officer,Company Secretary

Substantial Shareholders

Holding Name
0 (0%) Not Disclosed in Annual Report

Calendar of Events

Date Event
26 February 2016 Report (Interim)
29 September 2015 Report (Annual)
28 August 2015 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.